CYP450 3A4/5 Containment During SARS-CoV-2 Infection

Terrier, Jean; Lenoir, Camille; Samer, Caroline Flora

doi:10.1002/cpt.2725

Scientific article

Comment

English

CYP450 3A4/5 Containment During SARS-CoV-2 Infection

ContributorsTerrier, Jean

; Lenoir, Camille

; Samer, Caroline Flora

Published inClinical pharmacology and therapeutics, vol. 113, no. 2, p. 218

Publication date2023-02

First online date2022-09-08

Abstract

Comment on : Le Carpentier EC, Canet E, Masson D, Martin M, Deslandes G, Gaultier A, Dailly É, Bellouard R, Gregoire M. Impact of Inflammation on Midazolam Metabolism in Severe COVID-19 Patients. Clin Pharmacol Ther. 2022 Nov;112(5):1033-1039. doi: 10.1002/cpt.2698. Epub 2022 Jul 27. PMID: 35776074; PMCID: PMC9350233.

Keywords

Humans
COVID-19
SARS-CoV-2
Cytochrome P-450 Enzyme System

Affiliation entities

Research groups

Pharmaco-omiques et médecine de précision (1003)

Citation (ISO format)

TERRIER, Jean, LENOIR, Camille, SAMER, Caroline Flora. CYP450 3A4/5 Containment During SARS-CoV-2 Infection. In: Clinical pharmacology and therapeutics, 2023, vol. 113, n° 2, p. 218. doi: 10.1002/cpt.2725

Article (Published version)

Identifiers

PID : unige:177025
DOI : 10.1002/cpt.2725
PMID : 36076327
PMCID : PMC9538688

Additional URL for this publicationhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9538688/

Journal ISSN0009-9236

85views

133downloads

Creation06/02/2024 10:33:47

First validation14/05/2024 08:21:41

Update24/03/2026 14:24:45

Status update24/03/2026 14:24:45

Last indexation24/03/2026 14:27:16

Archive ouverte UNIGE

CYP450 3A4/5 Containment During SARS-CoV-2 Infection

Technical informations